Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Paroxetine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | GRK2 | P25098 | 4/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | CACNA1F | O60840 | 1/20 | 1.00 |
| ▸ | MPO | P05164 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Paroxetine SCHEMBL29358021 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL2583823 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL114238 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL10643985 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL1286957 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL8732632 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL15855060 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL1560678 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL1945816 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 | |
| Paroxetine SCHEMBL10643980 | 1.00 | CYP3A4 (1.00) | CYP3A4GRK2SLC6A4TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 52266 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144782-A1 | METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS | AUSPEX PHARMACEUTICALS LLC (US) | 2026-05-28 | — | — | US | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4746863-A1 | ENDOXIFEN COMPOSITIONS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF | Atossa Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122094963-A | Cardioprotective lipids and methods of use | — | 2026-05-26 | — | — | CN | claimed |
| CN-122079853-A | N-substituted indoles and other heterocyclic compounds for the treatment of brain diseases | — | 2026-05-26 | — | — | CN | claimed |
| CN-122036817-A | C-alkyl carbon glycoside and preparation method thereof | 江西师范大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| CN-122035985-A | Magnetic eutectic solvent, preparation method and application thereof, pretreatment method of antidepressant-containing wastewater and quantitative detection method | 山西医科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122031650-A | Eloralintide and paroxetine combined application, compound preparation and preparation method | 杭州昊肽生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260131089-A1 | DRUG DELIVERY DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO A BODY CAVITY BY HETEROGENOUS AEROSOLIZATION FOR TREATMENT OF BINGE-EATING DISORDERS AND/OR OBESITY | APTARGROUP, INC. (US) | 2026-05-14 | — | — | US | claimed |
| WO-1992000103-A1 | PHARMACEUTICAL PREPARATIONS | BEECHAM GROUP PLC (GB) | 1992-01-09 | — | — | WO | claimed |
| EP-0440704-A1 | COMPOSITIONS FOR TREATING TOBACCO WITHDRAWEL SYMPTOMS. | MASSACHUSETTS INST TECHNOLOGY (US) | 1991-08-14 | — | — | EP | claimed |
| EP-0386117-A1 | TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-09-12 | — | — | EP | claimed |
| WO-1990004387-A2 | COMPOSITIONS FOR TREATING TOBACCO WITHDRAWAL SYMPTOMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-05-03 | — | — | WO | claimed |
| WO-1989003692-A1 | TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-05-05 | — | — | WO | claimed |
| US-4804669-A | Treatment of pain with a piperidine | A/S FERROSAN (DK) | 1989-02-14 | — | — | US | claimed |
| EP-0269303-A2 | Piperidine derivative for treating pain | NOVO NORDISK A/S (DK) | 1988-06-01 | — | — | EP | claimed |
| US-4745122-A | PAROXETINE ADMINISTERED TO ANIMALS | A/S FERROSAN (DK) | 1988-05-17 | — | — | US | claimed |
| EP-0223403-A2 | Piperidine derivative, its preparation, and its use as medicament | BEECHAM GROUP PLC (GB) | 1987-05-27 | — | — | EP | claimed |
| EP-0188081-A2 | Use of paroxetine for the manufacture of a medicament for the treatment of obesity | NOVO NORDISK A/S (DK) | 1986-07-23 | — | — | EP | claimed |